Dew, I'm assuming ENTA hasn't given any rough guidance on expected royalties from Mavyret/Maviret for 2018. Do you have any thoughts on what to expect here for 2018? I freed up a little cash and just kicking tires on a lot of names to see what I want to play next. Seems like HCV can provide a nice floor for the stock going forward at a minimum and possibly decent upside depending on expectations then you have the rest of the pipeline that could drive upside depending on results.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.